Connexin 32 downregulation is critical for chemoresistance in oxaliplatin-resistant HCC cells associated with EMT

Background: Oxaliplatin (OXA)-based chemotherapy is critical in the management of advanced hepatocellular carcinoma (HCC); however, acquired drug resistance has largely restricted its clinical efficacy. This study aims to explore the key mechanisms and regulatory factors determining chemosensitivity...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Manag Res
Autors principals: Yang, Yan, Yao, Jing-Hao, Du, Qian-Yu, Zhou, Yong-Chun, Yao, Ting-Jing, Wu, Qiong, Liu, Jing, Ou, Yu-Rong
Format: Artigo
Idioma:Inglês
Publicat: Dove 2019
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6549660/
https://ncbi.nlm.nih.gov/pubmed/31213923
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S203656
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars